Patent · US Active

TLR7/8 antagonists and uses thereof

US10399957B2 · kind B2 · utility

2Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 16, 2016
Grant dateSep 3, 2019
Priority date—
Expiry dateDec 16, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TLR7/8 antagonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.